Cite
HARVARD Citation
Richard, F. et al. (2014). FRI0388 Effects of Blisibimod on Serum Immunoglobulins and Infection Risk in Patients with Systemic Lupus Erythematosus from the Placebo-Controlled PEARL-SC and Open-Label Extension Studies. Annals of the rheumatic diseases. pp. 527-528. [Online].